Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Oncotelic Therapeutics, Inc. (OTLC) had Pre-Tax Income of $0.21M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$0.28M |
|
-- |
|
-- |
|
$0.07M |
|
$-0.07M |
|
$0.28M |
|
|
Pre-Tax Income |
$0.21M |
$0.21M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
$-0.07M |
|
$-0.02M |
|
408.29M |
|
452.81M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.14M |
|
-- |
|
$26.54M |
|
$26.68M |
|
$19.29M |
|
-- |
|
-- |
|
$19.29M |
|
$7.39M |
|
$4.61M |
|
$7.39M |
|
408.29M |
|
| Cash Flow Statement Financials | |
$-0.29M |
|
-- |
|
$0.29M |
|
$0.11M |
|
$0.11M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
1.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.85% |
|
4.57% |
|
0.79% |
|
2.85% |
|
$0.02 |
|
$-0.00 |
|
$-0.00 |
|